June 2024: Hydroxychloroquine retinopathy monitoring service commissioned

News

June 2024: Hydroxychloroquine retinopathy monitoring service commissioned


NHS Devon has commissioned a hydroxychloroquine (HCQ) retinopathy monitoring service from an external provider (InHealth). HCQ does not require routine laboratory blood monitoring or physical health monitoring by the GP and therefore no longer fits the local definition of formal “Shared Care”.

The five existing shared care guidelines for HCQ in Devon (three for rheumatology patients (North & East Devon, South Devon & Torbay, and West Devon) and two for dermatology patients (South Devon & Torbay, and West Devon only)) have been withdrawn and replaced by an enhanced Devon Formulary entry.

The patient’s specialist will be responsible for referring the patient to InHealth. The service will offer annual monitoring for patients who have been on HCQ for five or more years, and one or more years if additional risk factors identified.

Click here for the formulary entry

Click here for further information regarding the retinopathy monitoring service

See here for other recent updates to the formulary